FindTrial
Sign In

A Study to Evaluate the Effect of Vasadi Syrup Along with Budesonide Nebulization in Reducing Night Time Symptoms of Bronchial Asthma in Children Aged 6 to 12 Years.

A randomized comparative clinical trial to evaluate the add-on effect of Vasadi syrup with Budesonide inhaled corticosteroid (ICS) nebulization in the management of nocturnal symptoms of Tamak Shwasa (bronchial asthma) among children aged 6 to 12 Years. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104159
Enrollment
35
Registered
2026-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Sponsors

PDEAs college of Ayurved and research centre nigdi Pune Maharashtra India 411044
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) A diagnosed case of Tamaka shwasa ( bronchial asthma) with nocturnal symptoms, including nocturnal coughing and at least two other symptoms (noisy chest, exercise intolerance, sleep disturbance at night), lasting for at least 1 year. 2) Patients in the age group 06 to 12 years, Irrespective of sex, religion, socioeconomic status, and occupation, will be taken.

Exclusion criteria

Exclusion criteria: 1) Acute bronchial asthma. 2) Severe respiratory distress. 3) Known cases of respiratory system infection, like tuberculosis, pneumonia, and bronchitis. 4) Known case of congenital diseases of the respiratory & cardiovascular System.

Design outcomes

Primary

MeasureTime frame
To assess the add on effect of Vasadi syrup with Budesonide (ICS) nebulization in improving bronchial asthma symptoms and lung function in children with nocturnal symptoms, Tamaka shwasa (bronchial asthma) over 7 daysTimepoint: 7 days study with follow up on 3rd,7th and 10th day—

Secondary

MeasureTime frame
1) To evaluate the change in PEFR (Peak Expiratory Flow Rate) throughout treatment. 2) To observe any adverse effect of Vasadi syrup & (ICS) Budesonide nebulization in children aged 6 to 12 years over 7 days. Timepoint: 7 days study with follow up on 3rd,7th & 10th day—

Countries

India

Contacts

Public ContactDr Sudha Singh

PDEAs College of Ayurved and Research centre Nigdi Pune

drsudha2010@gmail.com9975404439

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026